Immunization of Tg‐APPswe/PSEN1dE9 mice with A&bgr;3‐10‐KLH vaccine prevents synaptic deficits of Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Behavioural Brain Research

• Publication date

  2017-08-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbr.2017.05.056PMID 28577919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Developing therapeutic vaccines against Alzheimer’s disease

  2016influential reference
• An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice.

  2015cited by this paper
• Evidences for B6C3-Tg (APPswe/PSEN1dE9) Double-Transgenic Mice Between 3 and 10 Months as an Age-Related Alzheimer’s Disease Model

  2014cited by this paper
• Pathogenesis of Abeta oligomers in synaptic failure.

  2013cited by this paper
• BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

  2013cited by this paper
• Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections

  2012cited by this paper
• Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.

  2012cited by this paper
• Safety and biomarker effects of solanezumab in patients with Alzheimer's disease

  2012cited by this paper
• In Vivo Electroporation of a New Gene Vaccine Encoding Ten Repeats of Aβ3-10 Prevents Brain Aβ Deposition and Delays Cognitive Impairment in Young Tg-APPswe/PSEN1dE9 Mice

  2012cited by this paper
• Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease

  2012cited by this paper
• Orchestrated experience-driven Arc/Arg3.1 responses are disrupted in a mouse model of Alzheimer’s disease

  2012cited by this paper
• Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 reduces AD-like pathology and cognitive impairment in Tg-APPswe/PSEN1dE9 mice.

  2012cited by this paper
• Prion-Like Behavior and Tau-dependent Cytotoxicity of Pyroglutamylated β-Amyloid

  2012cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

  2011cited by this paper
• Amyloid oligomers: formation and toxicity of Aβ oligomers

  2010cited by this paper
• Review: Disruption of the Postsynaptic Density in Alzheimer’s Disease and Other Neurodegenerative Dementias

  2010cited by this paper
• Widespread changes in dendritic spines in a model of Alzheimer's disease.

  2009cited by this paper
• Quantitative and Mechanistic Studies of Aβ Immunotherapy

  2009cited by this paper
• Quantitative and mechanistic studies of Abeta immunotherapy.

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

  2009cited by this paper
• SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer' Disease: The Role of the Immune System in Clearance of Aβ from the Brain

  2008cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• Will anti-amyloid therapies work for Alzheimer's disease?

  2008cited by this paper
• The role of the immune system in clearance of Abeta from the brain.

  2008cited by this paper
• Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.

  2007cited by this paper
• Spatial relationship between synapse loss and β‐amyloid deposition in Tg2576 mice

  2007cited by this paper
• Neuronal damage in brain inflammation.

  2007cited by this paper
• Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.

  2006cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-β

  2005cited by this paper
• Immunotherapy for Alzheimer disease: the promise and the problem.

  2005cited by this paper
• Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.

  2005cited by this paper
• Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial

  2005cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-beta.

  2005cited by this paper
• Postsynaptic Density 95 controls AMPA Receptor Incorporation during Long-Term Potentiation and Experience-Driven Synaptic Plasticity

  2004cited by this paper
• Synapses with a segmented, completely partitioned postsynaptic density express more AMPA receptors than other axospinous synaptic junctions.

  2004cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis

  2002cited by this paper
• Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

  2002cited by this paper
• Associative Learning Elicits the Formation of Multiple-Synapse Boutons

  2001cited by this paper
• Generation of auto-antibodies towards Alzheimer's disease vaccination.

  2001cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper
• Keyhole limpet hemocyanin: structural and functional characterization of two different subunits and multimers.

  1996cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

  1990cited by this paper

• Active Immunization: A Novel Therapeutic Strategy for Treating Alzheimer's Disease.

  2025cites this paper
• Vaccines for Alzheimer's disease: a brief scoping review

  2025cites this paper
• A Novel Aβ B-cell epitope Vaccine, Aβ1-10 with carrier protein OVA and KLH reduce Aβ-induced neuroinflammation mediated neuropathology in mouse model of Alzheimer's disease.

  2025cites this paper
• Conditioned Media Therapy in Alzheimer's Disease: Current Findings and Future Challenges.

  2023cites this paper
• Novel Strategy for Alzheimer’s Disease Treatment through Oral Vaccine Therapy with Amyloid Beta

  2023cites this paper
• Locomotor Hyperactivity in the Early-Stage Alzheimer’s Disease-like Pathology of APP/PS1 Mice: Associated with Impaired Polarization of Astrocyte Aquaporin 4

  2022cites this paper
• Immunization with Aβ3-10-KLH vaccine improves cognitive function and ameliorates mitochondrial dysfunction and reduces Alzheimer's disease-like pathology in Tg-APPswe/PSEN1dE9 mice.

  2021cites this paper
• Multiple Antigenic Peptide System Coupled with Amyloid Beta Protein Epitopes As An Immunization Approach to Treat Alzheimer's Disease.

  2019cites this paper